Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-17 Purchase |
2024-09-19 11:02 am |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
56,106 | $1.3588 | $76,237 | 4,379,818 (Indirect Direct) |
View |
| 2024-09-12 Purchase |
2024-09-16 4:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
358,923 | $1.3494 | $484,344 | 4,323,712 (Indirect Direct) |
View |
| 2024-08-13 Purchase |
2024-08-14 8:48 pm |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
271,826 | $1.4002 | $380,598 | 3,964,789 (Indirect Direct) |
View |
| 2024-05-14 Purchase |
2024-05-16 08:58 am |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
414,281 | $1.5438 | $639,578 | 3,692,963 (Indirect Direct) |
View |
| 2023-08-28 Sale |
2023-08-29 5:04 pm |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $6.2757 | $98,058 | 148,975 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-23 7:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
100,000 | $7.0974 | $709,740 | 3,330,337 (Direct) |
View |
| 2023-05-08 Purchase |
2023-05-10 5:47 pm |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
125,000 | $8 | $1,000,000 | 2,188,713 (Indirect) |
View |
| 2022-09-01 Purchase |
2022-09-02 5:12 pm |
Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer |
7,500 | $3.393 | $25,448 | 45,455 (Indirect Direct) |
View |
| 2022-08-29 Purchase |
2022-08-31 5:47 pm |
Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer |
7,255 | $3.2038 | $23,243 | 37,955 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-05-16 08:56 am |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
0 | $0 | 3,692,963 (Indirect) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $1.8 | 148,975 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $0 | 148,975 (Direct) |
View |
| 2023-07-26 Gift |
2023-07-27 5:16 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
50,000 | $0 | 628,846 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 8:09 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:17 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director |
14,815 | $0 | 14,815 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:16 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:15 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:14 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:13 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:06 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:02 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:13 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Lam Jennifer VP of Finance & Administration |
90,000 | $0 | 110,600 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:11 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
125,000 | $0 | 160,600 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:09 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | FLESHER GREGORY J. President and CEO |
300,000 | $0 | 415,200 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:07 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer |
125,000 | $0 | 155,000 (Direct) |
View |
| 2022-08-12 Gift |
2022-12-13 6:07 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer |
22,348 | $0 | 155,000 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 6:06 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer |
125,000 | $0 | 174,455 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 5:10 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
50,000 | $1.97 | 696,252 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 5:10 pm |
2019-01-01 2028-04-04 |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
50,000 | $0 | 696,252 (Direct) |
View |
| 2022-08-02 Option Award |
2022-08-02 7:16 pm |
N/A 2032-08-01 |
Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:26 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:01 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
6,376 | $0 | 6,376 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
17,500 | $0 | 17,500 (Direct) |
View |
Ownership |
2022-04-05 8:02 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Lam Jennifer VP of Finance & Administration |
0 | $0 | 110,000 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 9:51 pm |
N/A 2032-03-01 |
Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:58 pm |
N/A 2032-01-19 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:32 pm |
N/A 2031-12-09 |
Reneo Pharmaceuticals Inc. | RPHM | Jindal Vineet R. Chief Financial Officer |
130,000 | $0 | 136,600 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:31 pm |
N/A 2031-12-09 |
Reneo Pharmaceuticals Inc. | RPHM | FLESHER GREGORY J. President and CEO |
300,000 | $0 | 309,600 (Direct) |
View |